News und Analysen

The GLP-1 market has grabbed considerable attention in the past couple of years, and there's little doubt as to which pharmaceutical companies dominate this space. Eli Lilly is currently the leader

In the pharmaceutical world, if you can't develop 'em, acquire 'em. That seems to be the philosophy behind Pfizer's (NYSE: PFE) latest big-ticket buy, specifically its purchase of clinical-stage

Want to invest in some low-priced stocks that possess a lot of upside in the long run? The stocks listed below could be great options for bargain hunters, as each one trades at less than $100 per

Remember Pfizer (NYSE: PFE), the giant pharmaceutical company that developed a COVID-19 vaccine within weeks of the pandemic hitting U.S. shores and got it approved within a year? It was the fastest

AbbVie (NYSE: ABBV) ranks as the third-largest pharmaceutical company in the world, with a market capitalization hovering around $390 billion. It markets around a dozen blockbuster drugs, plus many

Weight loss drugs have represented an enormous growth area for biotech and pharma companies over the past couple of years. Pharma giants Eli Lilly and Novo Nordisk dominate the market with their

The winds of political change have hit the healthcare industry, with drug makers seemingly taking the brunt of the gale. Industry-leading companies like Pfizer (NYSE: PFE), Merck (NYSE: MRK), and

The problem with trying to buy a stock at its low is that you'll only know whether it has bottomed out after it has done so. When it's in the midst of a sell-off, it's impossible to know how low

Pfizer (NYSE: PFE) is highly likely to survive the current headwinds it faces in the pharmaceutical sector. It has a long history and a strong core business. But it isn't the only drugmaker that's

A few years ago, Pfizer (NYSE: PFE) saw revenue soar to record heights thanks to coronavirus-related sales, from its vaccine Comirnaty and its treatment Paxlovid. On top of this, the company's

Shares of a little-known biotechnology stock called Metsera (NASDAQ: MTSR) popped on Monday, Sept. 22, after Pfizer (NYSE: PFE) announced it would be acquiring it for a steep premium. Under the

Strong dividend payers can be a stabilizing force in a well-diversified portfolio. That's because corporations that can consistently pay and raise their payouts over a long period are often

A victory on the regulatory front and a bullish analyst move were the twin news items propelling BioNTech's (NASDAQ: BNTX) shares higher as the stock trading week began on Monday. The Germany-based

Pfizer (NYSE: PFE), the one-time COVID vaccine hero turned Ozempic craze zero, is marching higher Monday after announcing it will try to recover from its danuglipron setback by buying another drug

It isn't easy to find a pharmaceutical company that has a strong product lineup and a robust pipeline, but also cranks out a generous dividend every quarter. I've been an AbbVie (NYSE: ABBV) bull

The major market indexes are bumping against all-time highs. It's not surprising, therefore, that many stocks are trading at steep valuations. There are, however, some exceptions that are still

Medtronic (NYSE: MDT) is out of favor today, noting it has a historically high dividend yield of around 3%. The company is working on improving its business performance, however, and stronger

President Donald Trump's trade policies have introduced plenty of volatility to the stock market this year. Steeper tariffs could impact consumer spending and the broader economy in ways that could

UnitedHealth Group (NYSE: UNH) stock has been one of the most interesting on Wall Street in the last few weeks. Following a brutal start to the year, the healthcare provider was the No. 1 performing

A bargain stock can be a great opportunity if you subscribe to the value approach to investing. If a stock is trading at a cheap price, but the company has strong business fundamentals and solid

According to some research, healthcare stocks are about as cheap as they have been in three decades. Many have experienced significant headwinds recently, but for opportunistic investors, now may be

It is tempting for a dividend investor to simply select the highest yielding stocks. The problem with that approach is that it exposes you to the risk of dividend cuts if the yield is too high for

Investors who bought shares of Intuitive Surgical (NASDAQ: ISRG) or Vertex Pharmaceuticals (NASDAQ: VRTX) 20 years ago and held onto them are likely pleased with their decisions. Both companies have

The list of Dividend Kings -- the very few U.S.-traded stocks that have enacted dividend raises at least once annually for a minimum of 50 years in a row -- is extremely short. That's why it's quite

The S&P 500 is offering a skinny yield of 1.2%. The average healthcare stock has a yield of 1.7%. Healthcare giant Pfizer (NYSE: PFE) is yielding a relatively huge 7.2%. Before you jump at that